A Phase II study of SHR-A1921, a TROP2-targeted antibody–drug conjugate, in patients with recurrent or metastatic salivary gland carcinoma

By Guangliang Chen, Yanjing Guo, Ya'nan Yang, Youzhou Sang, Sibo Sun, Xin Liu, Xin Zhou, Chun-Ying Sheng, Xiayun He, Jianfei Wang and 4 more. 2026